Article
Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias.
Anti-cancer agents in medicinal chemistry - 1 Jan 2019
Rumjanek Vivian M, Maia Raquel C, Salustiano Eduardo J, Costa Paulo R R
Abstract excerpt
In an attempt to find anticancer agents that could overcome multidrug resistance (MDR), two new classes of modified isoflavonoids were designed and synthesized, and their effectiveness evaluated against a vast array of tumor cell lines. Pterocarpanquinone (LQB-118) and 11a-aza-5-carbapterocarpan (LQB-223) were the most promising. LQB-118 induced cell death, in vitro, in the µM range, to a number of human cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
